Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · Real-Time Price · USD
3.880
+0.010 (0.26%)
At close: May 22, 2026, 4:00 PM EDT
3.890
+0.010 (0.26%)
After-hours: May 22, 2026, 4:10 PM EDT
Alpha Teknova Market Cap
Alpha Teknova has a market cap or net worth of $208.56 million as of May 22, 2026. Its market cap has decreased by -38.73% in one year.
Market Cap
208.56M
Enterprise Value
218.60M
1-Year Change
-38.73%
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since the IPO on June 25, 2021, Alpha Teknova's market cap has decreased from $433.79M to $208.56M, a decrease of -51.92%. That is a compound annual growth rate of -13.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 208.56M | 2.53% |
| Dec 31, 2025 | 203.41M | -54.30% |
| Dec 31, 2024 | 445.12M | 193.01% |
| Dec 29, 2023 | 151.91M | -4.25% |
| Dec 30, 2022 | 158.66M | -72.34% |
| Dec 31, 2021 | 573.68M | 32.25% |
| Jun 25, 2021 | 433.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evolus | 401.06M |
| Organogenesis Holdings | 342.27M |
| SIGA Technologies | 335.67M |
| Akebia Therapeutics | 273.62M |
| Aurora Cannabis | 204.97M |
| Anika Therapeutics | 197.99M |
| Lifecore Biomedical | 184.92M |
| Journey Medical | 164.11M |